BQ Prime's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BQ Prime's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
An analysis of global merger and acquisition data reveals that year-to-date CY22 transactions (Jan-Sep 2022) have declined in value to under $3 trillion from $3.7 trillion during the same period a year ago.
We have found that healthcare and pharma/oil and gas have 11.4%/8.9% share, with M&A deals worth $350.3 billion/$273.3 billion. The no of large deals of $5 billion plus for year-to-date CY22 were 58 or at least 10% of the global M&A deals in value terms.
The latest deal of private equity firm Advent taking over Suven Pharmaceuticals Ltd. at aggregate deal market cap of Rs 128.9 billion ($1.56 billion) implies FY23E enterprise value/sales of 9.5 times and EV/Ebitda of 22.8 times.
This poses a challenge for PI Industries Ltd. for their stated plan to acquire an active pharma ingredient/contract development manufacturing organisation asset, as PI Industries may have to pay Rs 94.8-Rs 189.6 billion for 100% buyout of a similar asset with revenue of ~Rs 10-20 billion.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
